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In introducing clinical tr~~splantation, it viII be worth focusing upon 
certain phenomena which have been seen after whole organ transplantation 
under immunosuppression, whic~ form the basis for the clinical discipline 
,-. .. 
of transplantation, but which have not yet been precisely a~4. satisfactorily 
explained. 
Major progress toward the objective of tissue transplantation has been 
achieved only in the past fe~T years. Before then, an' almost total ignorance 
of the barriers which would be enc?untered after transplantation precluded 
the development of appropriate methods of therapy. Definition of the 
fundamental biologic problem came about 30 years ago from the studies of 
Sir Peter l1edawar and his colleagues in E.""lgla.l1d. 
l-1EDAHAR'S CONCLUSIONS 
Medawar's investigations were carried out with r~bbits in w~~ch the 
genetic homogeneity of the donor and recipient an~s ~s sufficient to 
permit a reasonable reproducibility of results. The conclusions vere 
precise. 
First, skin grafts were rejected. Ll about 10 days. Second, there vas 
evidence that the repudiation was due to an.immunologic reaction of the 
t 
host to the foreign tissue. The key observation in support of Jt.his con-
cept was the fact that a second skin graft from the original rabbit donor 
vas destroyed in an acceleratedf~shion, suggestingthe-acq~sition of 
immunity by the host. The il:i:i::lunit~· conferred by contact with the first 
graft vas permanent or of long dun.tion, and pertained to all tissues sub-
sequently transplanted from the donor. The sensitization was specific 
inasmuch as grafts from other donor strains vere not usually rejected in 
__ - ___ . __ ". ______ • __ . - __ . _.0. __ •. .!.. ___ . 
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an accelerated manner. The initial delay between the actual transplanta-
tion and the subsequent development of active immunity prompted comparison 
be"tween these events and the delayed hypersensitivity which permits 
immunity to develop to diseases like tuberculosis. 
, .. 
NCMENCLATURE . 
The terminology used in transplantation is based upon genetic and phylo-
genetic relationships which, in turn, roughly determine the hostility with 
which a graft is viewed by its re:ipient. When tissue is transplanted 
from one location to another place on the same host (an autograft), it is 
identified as "self" (Fig. 1) and does not, therefore, evoke a defensive 
host reaction. The success or failure of the graft is exclusively depen-
dp.nt. upon the technical adequacy of the procedure and upon other ,,!ell 
accepted principles of surgical care. Similarly, tissues exchanged 
between identical twins (isografts) are not recognized as foreign inasmuch 
as there is total genetic identity of such twin donors and recipients. 
This was first proved in man by Dr. J. B. Brown of St. Louis with skin 
tra..Tlsplantation experiments and later by the transplantation of kidneys 
(J. E. Murray) and bone marrow between identical twins. 
Ti~bue transplanted fran. non-identical members of the, same species 
, 
(Fig. 1) are called homografts (or allografts). The host response 
(reiec"tion) has an intensity which is roughly determined by the degree of 
. -
geneti? dissimilarity between donor and recipient. The,genetic factors 
of tr!lllsr-lantation, often referred to as Snell's Laws {aft"er Dr. George 
-- -..,.- - _. -----.. ---.--- r 
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Snell) were pracisely worked out in inbred rodent experiments. Unfortu-
nately, in the outbred canine and human populations, there is a tremendous 
and as yet unpredictable variability in the vigor of the attack which a 
homograft will elicit. These observations have led to an intensiye search 
for methods which would allow identification of"a favorable donor:recipient 
- .' 
combination in advance of clinical transp~antation. These techniques are 
referred to as tissue tvning, a subject to which we will return later and 
which will also be covered by Doctors van Rood ani Dausset. 
If transplantation is from a donor belonging to a different but similar 
species, the tissue is called a hetero~raft and on the average the rapidity 
and intensity of rejection are even greater than with hamografts. However, 
studies with chimpanzee to human renal heterografts pioneered 'b-f Dr. Keith_ 
Reemtsma have shown that suc.h transpla."1ts can sometimes be tolerated for 
long periods in patients who are receiving immunosuppressive therapy (maxi-
mum patient survival, 10 months). 
Tissues or organs transferred between widely divergerit species (as, 
for example, between pigs and dogs) are called xenografts. In most in-
stances, xenografts are destroyed within a few hours by a kind of hyperacute 
rejection which is apparently ~cs~rved by preformed heterospecific humoral 
antibodies. 
, 
MECHANIs-fS OF REJECTION 
Cell-m ~diatedImnnmi ty . 
There is abundant evidence that l:nnphocytes participa~e in the rejection 
.. 
process in an important way as 'Was illustrated by experiments of the late 
Dr. Glenn Algire, using millipore chanbers. He transplanted free fragments I 
of tissue which were shielded qy a mesn barrier of appropriate size inter-
stices to exclude lymphocytes and other Dononuclear cells but which vere 
, .. 
exposed to nutrient fluid and even red cells (Fig. 2). surVival of the 
grafts was longer than with tissue tt1..st was not thus protected. 
The participation if not the precise action of mononuclear cells in 
the unmodified (or ineffectively modified) rejection of tissues and organs 
can be appreciated in a more direct way by histopathologic studies vhich 
reveal massive infiltration by lymphoc:rtes and plasma cells. Coinciden-
tally, the blood supply to whole org~~ grafts is diminished and later all 
but cut off so that more or less complete ischemic necrosis is the ultimate 
fate of the transplant if the recipient ~imal lives long enough for this 
stage to be reached. The various hall1:arks of classical unmodjf'ied cellular 
rejection are much the same in all acutely rejecting organs, whether these 
. 
be liver, kidney, heart, or skin. 
Humo~al Jntibodies 
The cellular immune response :us not the only means by which delayed 
homograft rejection can occur. In the seruJJl of patients undergoing acute 
~ 
rejection, C,Ytotoxic or other kinds o~ antibodies have been described. 
Even in the serum of patients who have tolerated renal homogra~s for 
years, there are often circulating: antigraft antibodies,· bu.t in these_ 
cases apparently with a low capacjty to cause transplant ~jury. Neverthe-
.. 
less, homografts in such recipients CQil:l1only contain deposits of gazmna 
globulin, as well as host .complement. 
Antib?dy deposition has been very veil documented after transplantation 
~-- . " 
5. 
of human kidneys, livers, hearts and lungs. The patterns of the immuno-
globulin binding are particularly interesting in renal grafts since they 
reseoble those of two major kinds of experimental glomerulonephritis, 
namely Masugi nephritis caused by anti-GEM antibody and the kind of 
nephritis caused by the filtration by the kidn~y of soluble antigen-
, ,:. 
antibody complexes. In many cases, the glomerulonephritis in' these trans-
plants has been similar or identical to that vhich destroyed the native 
kidneys, indicating a recapitulation of the original disease. Hovever, it 
may also be said that glomerulon.ephritis can be one manifestation of humoral 
homograft rejection. This position has received 'support fr')m the fact 
-
that "glomerulonephritis" has been observed in homografts transplanted to 
recipients whose renal failure was due to polycystic kidney disease, 
cystinosi~, p~r",,1.oT1p.phrit.is or other di.sorders not susoected to be of 
autoimmune etiology. 
In other organs, such as the liver, immunoglobulin deposits have been 
somewhat less extensive than in r.~nal homografts and they have tended to 
be unevenly distributed throughout the vasculature. 
Presensitization States 
Second Set Rejection --- In Hedawar' s original experiments, ~kin trans-
planted to rabbits that had been sensitized by one exposure to donvr tissue 
. , 
vere rejected in an accelerated, or second set, fashion •. Instead of being 
repudiated after an average of 10 days, this time was shortened to 6 days. 
The aSstIr!lption vas (an-d still ls-) that-lymphoid tissue- or other~-coritributors 
to cell-mediated immunity were mobilized more quickly than normr.l t'3cause of 
r 
. ' .". 
• 
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prior antidonor instruction. An additional role or circulating humoral 
antibodies may a1. so be important • 
After whole organ transplantation under imm~~osuppression, there ha7e 
been numerous reports of accelerated rejection apparently comparable to 
that in Y.edavar's rabbit system. It has been speculated that the- advance 
... 
sensitization in these humans could ha7e"been induced by antigens 'also 
found in donor tissues during the course of pregnancies, by the previous 
·.administration of white cells or platelets in multiple blood transfusions 
or by other means including prior renal homotra."'lsplantation. In such 
patients, rejection occurs earlier and often more vigorously than expected 
but it does not necessarily proceed to immediate destruction of the graft. 
Reversal of this kind of uncomplicated accelerated rejection has often 
been observed (Fig. 3). 
Preformed Antibodies and P.voeracute Homograft Rejection --- The first 
clear examples of hyperacute rejection of renal homografts were in patients 
who received kidneys from ABO blo9d group incompatible donors. An effec-
tive blood flow to some of t,hese transplants was not restored when the 
vascular anastomoses were opened. The small vessels of the excised 
kidneys were demonstrated by angiography to be closed and, histop'lthologically, 
the arterioles and capillaries were plugged with formed b+ood elern~~ts, 
, 
particularly erythrocytes (Fig. 4). A rational although partial immunologic 
explanation was available since the blood group substances whict allow red 
- - ~elis to be ~yPQd~d b~~ sh~~ by HBgman and S~ulman~ toaiso' be f~tmd' 
in other tissues including the kidneys. Consequently, it: the kidne:;7 of 
. 
" . 
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an A, B, or AB donor were placed in a patient whose serum contained 
naturally occurring anti-A and/or anti-B isoagglutinins (an example 
would be a recipient with 0 blood type ..,.ho would have both kinds of iso-
agglutinins), these antibodies might be predicted to bind W'ith the renal 
red cell antigens. Serologic studies in some of our cases ~~9wed·that 
.falls in systemic isoagglutinin titers did, in fact occur. The rUles of 
red cell compatibility as they apply to whole organ transplantation are 
summarized in Table I. 
Hyperacute kidney rejection in the presence of red cell group comoati-
bility has baen seen with increasing frequency and, in fact, this kind of 
rejection has become the chief cause of acute homograft loss in most major 
transplantation centers. The first case was described ~. Dr. Paul Terasaki 
of. Los AngA1As i.n R. !lA.tient whose serum conbdnp.d lympho~ytot.ori ~ A.nti-
bodies that killed donor cells. Terasaki theorized that, in the course of 
being transfused prior to operation, the recipient had been immunized 
(probably on multiple occasions) to white cells that shared histocompati-
bility antigens with the eventual renal donor. Since then, no one has 
seriously challenged this general hypothesis of presensitization. The 
concept has been indirectly supported by the bighrate of hyperacute rejec-
tion ~ith retransplantation in patients whose first hamografts were rejected 
, 
and who were thereby presumably immunized to some antigens also present 
in the ~econd graft. 
Subsequently, many other authors p~ve confirmed the adverse implications 
of pl.-eformed antidonor antibodies as detected with several techniques. The 
8. 
most commonly employed methods have measured 1ymphocytotoxins and 1euko-
agglutinins but the most sensitive examination has been said tTl G. M. 
Williams and Felix Milgrom to be the mixed agglutination test. 
While certain tests may be more sensitive t~ others for th~.detec-
.' 
" .-
tion of the preimm~ized state, it does ~ot seem likely that a single 
antibody will be found to have unique predictive significance. In our 
laboratories, deliberate sensitization of dogs b.y repeated skin grafts led 
to the formation of a variety of antiwhite cell and antired cell antibodies, 
with antidonor reactivity. However, the titer of these antibodies is not 
well correlated with the rapidity of· rejection of a kidney from the skin 
donor. J.loreover, it has been emphasized in reports of clinical cases that 
hyperacute rejection which is presumably due to presensitization may occur 
even though anti donor antibodies cannot be found with any currently avai1-
able technique including the mixeu-agglutination method. Under these. latter 
circumstances it has been necessary to assume that an i.l:m;nediate, albeit 
undiscernible, immunologic reaction is the initiating event in the destruc-
tive process that follows. With or without demonstrable antibodies in the 
redpie."lt serum, the immunoglobulin deposition in the transplants may be in 
such small quantities that their specificity as judged b.y strictly morpho-
~ 
logic criteria in immunofluoroscence studies could be" open to question 
even though on other grot;nds i~ is reasonable to believe they are significant. 
One view of hyperacute rejection might be that. the ailtidcmor- utibodies 
., 
diS\';'lSS~d in the preceding section were destructive of renal homografts by 
.. 
their direct nephrotoxicity. The ~bservations already cited in the ABO 
.. 
-----------------
• 
incompatible cases were not consistent with such a conclusion sin~e the 
most obvious lesion in the rapidly repudiated kidneys was occlusion of 
their blood supply by .clot and mechanical debris including formed blood 
elements. 
In cases with hyperacute rejection despite red cell compatibility, 
there has also been evidence of interference with the blood sUpply. In 
hyperacutely rejected kidneys, the glomerular capillaries and the arterioles 
are full of microthrombi making the morphologic features indistinguishable 
from those of a generalized Shwartzman reaction. The consequence is 
devascularization of the kidney and cortical necrosis. 
The explanation for hyperacute rejection that has evolved in the past 
3 or 4 years is based upon interlocking relationships between several 
the graft blood supply. In sensitized recipients, it is clear that a 
transplanted kidney almost immediately becomes a trap for antidonor anti-
, 
bodies, formed blood elements and-clotting factors. The removal of these 
various substances occurs almost simultaneously. Nevertheless, it must 
be assumed that an antigen-antibody reaction induces the clottin~ process, 
presumably with the collaboration of pOlymorphonuclear leukocytes. 
An understanding of the pathogenesis of hyperacute rejection ~v help 
. , 
in the development of methods of therapy. Although clotting is prominent 
in this vicious kind of reject"ion, :the use of potent anticoagulants, 
" .. - --- - ,,-. - - '"" .. 
including heparin and cobra snake venom, have not provided effective prophy-
• laxis. In co~trast, the intra-arterial infusion of either citrace or ethylene-
diamine tetracetic acid (EmA) is of great benefit, apparently secondary to 
10. 
calcium binding. Calcium has an essential role in the clotting process, 
but it is also vital to the activation of complement. Since citrate and 
EDTA therapy impose predictably high risks under the laboratory conditions 
tested so far, these drugs have not yet been us~ clinically. 
Within the last few months, Kobayasr~ of Boston has reported some 
potentially practical experiments in which organ pretreatment was carried 
out prior to transplantation. Monkey kidneys were perfused with pepsin 
digested F(ab)2 fragments cade from the serum of an animal specifically 
sensitized against the organ donor·. The non-complement binding iIImnmo-
globulin fragments prevented the subsequent hyperacute rejection of these 
organs after transplantation to the sensitized original serum donors. 
Hyperacute Xenograft Rejection --- In recent years, it has been thought 
on the basis of indirect evidence that the violent rejection occurring after 
xenotransp1antation between divergent species was initiated by t:1e action 
of preformed heterospecific antibodies. Support for the hypothesis included 
, 
the fact that antidonor antibodies of several kinds were often demonstrable 
qy preoperative in vitro testing of the recipient animal's serum, that 
such antibodies were cleared qy orgai1S transplanted from this donor, that 
the vascularization of successive kidr.eys from the same donor (or donors 
t 
of the same species) usually prolonged the function of the 1asb organ pre-
sumably qy antibody depletion, and that~ysiochemica1 removal of immuno-
globulins or the inactivation of ~o!llplement in the recipi~nt someti1lies in-
creased heterograft survival • 
• 
• 
ll. 
It has been of considerable interest to compare the events of hyper-
acute xenograft rejection to those which abruptly lead by unquestionably 
immunologic mechanisms to the destruction of homografts that are placed 
into recipients deliberately sensitized ·to don~~ tissue (se~:prec~ding 
section). The observations have been so similar in each circumstance 
that progress in ameliorating hyperacute rejection would be expected to be 
applicable to both situations. This prediction has been strikingly ful-
filled in that both the citrate ~nd EDTA therapy described in the preced-
ing section can prevent the rejection of porcine to canine renal grafts 
for as long as a half day. If untreated, such kidneys fail within 2 
to 10 minutes. 
IMMUNOSUPPRESSION 
~or a number of years after the features of cell~ediated rejection 
were defined, the not unreasonable assumption vas made that this process 
, 
was one of nature's most powerful and perservering reactions which could 
be prevented only by relatively complete crippling of the host'~ natural 
defenses. Such fears of lethal immunologic invalidism appeared fully 
justified by the consequences of total body irradiation. In ord~r to be 
~ 
effective, this kind of recipient modification required doses sufficient 
to cause bone marrow depression. There was a consequent acute mortality 
which was so excessive that clinical organ transplantation proved to have 
little chance of success from the years 1957 to 1962 durLog which total 
body irradiation was given a number of clinical trials. Nevert~e1.ess, 
.. 
there vere two patients treated before 1962, who survived more than a 
decade after renal transplantation under irradiation, one from Boston and 
the other from Paris. Both of these recipients were given kidneys qy 
fraternal (non-identical) twins. 
". 
.' Clinically Important Drugs 
Azathionrine --- A highly significant subsequent advance was the 
I 
development of azathioprine, a potentially radiomimetic drug with the pre-. 
dominant effect of inhibiting DNA synthesis •. 'vlith this drug, chronic homo-
graft function could often be obtained without the need for doses large 
Enough to cause leukopenia. For the first time, whole organ grafts could 
successfully be performed in dogs in a standard laboratory environment 
in which no extraordinary infectious precautions were taken. 
Qyclophosnhamide --- Almost a decade ago, cyclopnospnamiu~ was ~lv~ 
a ver:' brief clinical trial for renal homotransplantation, but was promptly 
abandoned because of its toxicity. Within the past year, cyclophosphamide 
was reintroduced at our institution as a substitute for azathioprine in a 
triple drug combination that also included heterologous antilymphocyte 
globulin (ALG) and prednisone. More than 100 human recipients ~f livers, 
kidneys, and hearts have been treated vi th this regimen. 'The conclusion 
from t!lese studies has been that cycloPLlosphamide is ~ui...talent to =ozathio-
, 
prino 8S a component of this kind of drug combination. As ~ interesting 
i'ootnote, it may be noted that cyclophosphamide does not_.mitigaterenal 
. . 
homograft rejection in dogs although it is a very potent immunOst-:pp~essant 
. 
• 
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in rodents or in humans. Lack of success in the canine model probably 
greatly inhibited and delayed the vide spread clinical use of this important 
drug. 
Adrenal Corticosteroids --- Cortisone, th~.first major imm~~suppressa~t 
to be discovered, was described by Billingham, Krohn, and Hedawar .in 1951 
to delay the rejection of first set skin grafts in rodents. Krohn demon-
strated in 1954 that cortisone could partially abolish a pre-existing state 
of delayed hypersensitivity in rabbits. The crucial role of prednisone 
for the control and reversal of the rejection process has been unequivocally 
establisned in cases of clinical whole organ transplantation ~~der conditions 
to be described later. 
Heterologous Antilymphocyte Serum --- Since 1965, heterologous antilynpho-
cyte serum. (ALS) and its globulin derivative (ALG) have received ~"l enOr!!lOUS 
amount of attention and since 19b6 ALG has been used clinically with in-
creasing frequenc'y. The ALS is obtained from animals (such as the horse) , 
pre~~ously immunizedagain5t the lymphoid tissue of the sp~cies which is 
eventually to be treated (Fig. 5). For example, horses can be inoculated 
vitil b1lJlall lymphocYtes obtained from spleens, lymph nodes, thymuses, thoracic 
duct lj'lIlph, or tis~e culture. The resulting antibody response of the 
horse can be measured b.Y determining the ability of the serum' to agglutinate 
or to lyse human white cells in vitro. After intensive immunization the 
equihe titers -may rise to spectacular hAights;. antiwhite cell titers of 
1::6, COO are not at all unusual. 
• 
." 
.. 
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The serum collected fr~ an icmunized aninal is a powerful iromuno-
suppressive agent when given qy a variety of routes to members of the 
lymphoid donor species. In patients, Ate is usually given intramuscularly 
in combination with azathioprine (or cyclophosphamide) and prednisone 
and its use is limited to the first few postoperative months. ,. ~ administer-
ing ALG within these guidelines, the risks of foreign protein sensitization 
and anaphylaxis are minimized. 
Drug Synergism 
In dogs, a~d probably in humans as well, coneistent survival after 
renal homotransplantation is not obtainable Qy treating solely with any 
one of the four immunosuppressive agents described above. Consequently, 
the clinical application of organ transplantation r~s been based upon the 
vas widely exploited was azathioprine plus prednisone, hereafter referred 
to as the "double drug" regimen (Fig. 6). In 1966, heterologous ALG "'8.S 
added to make the "triple drug" regimen (Fig. 7), that ha~ become increas-
ingly widely used. Finally a triple dr~g program has received an extensive 
used 
clinical trial in the last year in which cyclophosphamide has been/in place 
of azathivprine (Fig. ?). 
CHANGING HOSI-GRAFr RELATIONSHIPS , 
There has been for so-.ne time an impressive body of information indicat-
ing t~at vho.le--organ homotransplantation 'With the· immun.os-u.ppressants described 
above car. eventually lead to selective abrogation of the host rejection 
.. 
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response, that the success with vhich this can be done is related amongst 
other things to histocompatibility factors, and that the degree to vhich 
it is achieved is the most important determinant of prognosis in any given 
case. Appreciation that the immunologic relation of the graft to the host 
'0. ._ 
is a fluid rather t~ a fixed one adds a~ important dimension to the con-
sideration of any kind of immunosuppression. 
Rejection and its Remission 
There are tvo clinically identifiable phases in the chain of events 
under discussion. The first consists of an attack by the host's immune 
defenses upon the new organ, usually within a few days or \leeks after its 
transplaJltation. The vigor of the process is highly variable, as judged by 
the magnitude of the changes caused in the morphology and function of the 
homograft. 
The remission of rej ection \-re:: not convincingly demonstrated in animals 
until it had been seen following clinical renal homotransplantation. The 
first indications that rejection was a highly controllable and regularly 
reveraible phenomenon, and tlmt it was often folloved ~ a state of relative 
"host-graft nonreactivity," came from observations of a number of patients 
who ~d ~lear-cut rejections commencing from a fev days to several veeks 
t 
after operation. The process was regularly reversed Oy the addition of 
massive doses of prednisone to thQ pre-existing therapy with azathioprine 
{Fig. 6).. Then, within a surprisingly short time it became.possible to 
drastically reduce the steroids that initially had been n~cessary to rescue 
.. 
the fI'afts (Figs~ 6, 9): In reveral instances the patients vere soon returned 
16. 
to treatment only with azathioprine, the agent which at the beginning had 
not been capable of preventing an acute rejection crisis (Fig. 9). Many 
of these patients are still alive 9 or 10 years later. 
There is no point in commenting further about the fully accepted fact 
". 
that kidney rejection ~an ~~dergo remission beyond noting that· such an 
occurrence is uncommon in dogs and probably also in humans if immunosuppression 
is not increased with steroids playing the central role in the intensification 
of therapy. 
In laboratory animals, there have been histopathologic studies vhich 
support the idea that an initial forceful host attack can subsequently tend 
to exhaust itself or at best to become less effective. Initially, the homo-
grafts become invaded with mononuclear cells, even in same animals which 
are not undergoing biochemical and clinical signs of rejection. In surviv-
ing animals, the infiltrate in various kinds of grafts may decrease in 
density or disappear. Subsequently, the predominant morphologic changes 
usually become those of repair and/or regeneration. 
Mechanisms of Graft Acceptance 
.\lthough it has. been well established that a homograft may come to be 
more o~ less tolerated in its new host, the explanation for the privileged 
status i~ not accepted with any more unanimity today tltan it wa~ five years 
. 
ago. Probably, more than one immunologic pathway may be involved. 
·Specific I1!Imunol.ogic Tolerance -- It ia-almost certain. that the con-. 
, 
tinuor.s presence of a transplanted organ in a host being t:reated with iromuno-
, 
• 
suppressive therapy ,often leads to a selective loss of reSponsiveness to the 
_._----_._-----_. --.----..... -.- ....... ---------
- -~. -
antigens of the homograft (tolerance). The evidence that ch~otherapy 
can be used for the induction of narrow range tolerance is unequivocal. 
The literature on this subject will not be reviewed here since it has 
17. 
been well summarized by Dr. Robert Schwartz, who w'aS the first to call 
attention to this possibility. Suffice it to s~y that azath!9prtn~, 6-
mercaptopurine, amethopterin, cyclophospr~de, and even tota~ body irradia-
tion can be used to promote specific tolerance, providing the antigen in 
question is administered in an appropriate dose and in close temporal ap-
proximation to the immunosuppres~i~e treatment. 
One of the theories to explain the specific effect of chemotherapy 
under these circumstances is depicted in Fig. 10. The illustration suggests 
that a clone of lymphocytes which presumably have an active metabolism as 
to antimetabolites. This concept of "clone stripping" is consistent with the 
c,yclic phenomena which actually do occur characteristically after whole organ 
transplantation both in treated animals and man in that the first evidence 
of graft "acceptance" is often coincident with or just after reversal of a 
rejection. 
Enhancement --- If specific itmn\ln('logic tolerance were the sole explana-
tion for graft "acceptance" it shoulQ oe possible to then successfully 
. , 
transplant other tissues from the -same donor. This later step is often not 
possible in 'carefully controlled animai experiments, suggesting instead 
some change in the primary graft wr.d.ch gives it a privileged status •. Many 
years ago, it was shown by Kaliss i!l tliiD.Or systems that homografts may be 
·a-" ., 
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protected by the presence of certain kinds of antigraft antibodies (en-
hancement) ~ It is conceivable by a feedback mechPnism that the same thing 
occurs under the conditions of whole organ transplantation. The process 
could be envisioned as shown in Fig. 10, whereby immunoglobulins SJ~thesized 
-by the activated clone return to the target tissue and coat or protect it 
in some way. The means by which this might occurare obscure since by and 
large the finding of host immunoglobulins in a homograft by immunofluoresc~,ce 
tecP~iques does not connote a favorable prognostic sign but rather the con-
verse. 
Recently, Hellstrom and Hellstrom of Seattle p~ve published with Fierce 
and Marchioro some observations tr.at may be related to enhancement. They 
showed that the serum of patients 1Il".i..~h wt:ll acct::lJi,eu. nm&.l hvill0g1'd.ft.~ ~Oi1-
tain antibodies that are capable of IIblocking" the cytotoxic action of 
recipient lymphocytes upon donor'tissues. Further characterization of these 
blocking antibodies and their biologic significance is one of the most 
active areas of applied immunologic research. 
failure of Antigen Processing --- There is the added possibility tr~t 
a defec:t :;.n antigen processing by the reticuloendothelial system could be 
responsi~le for graft acceptance, a concept for which there is not yet 
. , 
any firm evidence. However, it is mown that antisera can under certain 
cir~~tanc~s markedly and specifica~y inhibit for long periods the res-
- ~ - . -
ponsivaness to antigen recognition. The way in which an analogous 
, , ' 
.. • 
seque~ce of events could be hypothetically injected into the picture after 
organ transplantation is shown in Fig. 10. 
. ' 
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THE PRACTICALITY OF CLINICAL RENAL TRANSPLANTATION 
Although the primary par-pose of this article is not to present 
clinical data, a brief statement is in order about what has been achieved 
". .. 
so far with transplantation of the kidney. The modern era of ' renal trans-
plantation began in late 1962 and early 1963, from which period there are 
still about two dozen patients living who have had continuous . sub-
sequent function of their grafts. Subsequently, thousands of patients 
have benefited from renal homotransplantation and h£ve thereafter under-
gone relatively complete social and vocational rehabilitation. This has 
been particularly true in recipients of consanguineous grafts who now can 
expect to survive the first post-transplantation year at the rate of ap-
prOximately ~O~ (fig. 11). It is less true 01' recipients of· unrelat.ed 
(cadaveric) transplants in whon only 60 to 80% of grafts function for as 
long as a year (Fig. 12). 
In successfully treated patients there has not been the theoretical 
impas~e referred to earlier of having an unacceptable susceptibility to 
infec~ion. These patients have not required a controlled bacteriologic 
enviror:ment after discharge from the hospitals. All that is necessary is 
\ that the)- seek prompt medical attention if they develop any kind of i.LL-, 
fectious disease. Then they can u~lly be treated success.f\1l.ly 'With anti-
biotic~ -:>r other standard measures. --The reason vhy-this ldn~· of hapPY'· 
outcOlDa is so often possible is that complete host crippling is not required 
~ - . 
to ac.u.eve n graft acceptance," a3 was explained. in an earlier section. 
20. 
Thus, although there is al~ys an increased risk of infection, tp~s is not 
• 
so grave as to vitiate the value of the procedures. 
The other highly identifiable risk of chronic immunosuppression is an 
.' increased incidence of de nQYQ malignancy. From the premises' of Burnet and 
Thomas about the immunologic control of malignancy (surveillance hypothesis) 
it could have been predicted, and was, that an increased incidence of de nQYQ 
tumors would develop in people with naturally occurring immunologic deficien~ 
diseases or in patients whose immune reactivity was deliberately depressed 
in order t~ permit their acceptance of organ homografts. The hazard of malig-
nancy consequent to spontaneous immunologic deficien~ is so yTeli known from 
Dr. Robert Good's surveys that it will not be reviewed here. 
Analogous da~a in ia~rogenically immunosuppressed transplant recipients 
was not publicized until the spring of 1968. Since then, more than 60 
examples of new malignancy in transplant recipients have been recorded in 
an informal registry maintained at the University of Colorado. More than a 
third of these neoplasms have been of the lymphoreticular system. The main 
practical consequence of this information is that chronically :i.nmrl~osuppressed 
patients should be watched closely for any evidence of new growth. &:.rly 
diagnosis is especially important since many recipients with this col.':,lica-
. , 
tion have now been cured with standard means of treatment including excision, 
irradiation, and even chemotherapy--especially if this therapy is combined 
with a lightening of immunosuppression • 
• 
.. 
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TISSUE TYPING PROCEDURES 
It would be sup3rfluous as well as presumptuous in this discussion 
to do more than briefly allude to the role of tissue typing in clinical 
transplantation since the subject will be SO thoroughly covered:~J at 
least two and possibly all of our distinguished colleagues on this ~posium. 
a 
In our center, all donors and recipients are typed prior to operation for 
the HL-A antigens by the serologic techniques of Dr. Paul Terasaki. FroIl 
a practical point of view the most important test is a direct cross match 
between donor cells and the recipient serum to rule out the presence in 
the recipient of antidonor cytotoxic antibodies. If such antibodies are 
present a hyperacute (or at least an accelerated) rejection is apt to 
follow, for which reason it is now recognized to be a culpable act to 
proceed under these adverse conditions if there is any prospect of avoid-
iog them. 
Except to predict hyperacute rejection, tissue typing has not played 
a major role in our own transplantation practices. The reason is that a 
strong correlation between A. good serologic "tissue matchll and the :.linical 
outcome has not been evident except in a few special cases of sibling trans-
• plantations. Consequently, we do not place reliance upon tissue t7Pi~~ 
as a me$\.IlS of matching up donors and recipients. It is particularly im-
portant to realize this in cadaveric cases in which a recipien~ could be 
, 
given an unwarranted good prognosis on the basis of good tisl?Ue matc.h, or, 
~ 
alternatively, could be denied a cadaveric kidney on the groUnds that it 
could not succeed because of'~he presence of a bad match. 
.. . 
22 • 
It should be emphasized that methods of tissue matching are available 
in addition to the serologic ones just alluded to. Mixed lymphocyte 
culture techniques (HLC) should be ouch nore discriminating, but th~se 
,-. .-
require the better part of a week to be co:npleted, a time that'- is ~ch 
too long to permit practical application in most cadaveric cases. 
TRANSPLANTATlml OF EXTRAREnAL ORGANS 
Transplantation of extrarenal organs hRs not yet become practical to 
an extent comparable to the kidney in spite of the fact that the feasi-
bility sta.ge of liver, cardiac and lung transplantation has already been 
passed. There are a number of reasons for the high failure rate after 
transplantation of the extrarenal organs, but for the most part these 
reasons are non-immunologic. They include grea~er technical difficulties; 
the lack of artificial organs comp~~able to renal dialysis which could 
tide the hepatic, cardiac, or pulmonary patient over transient periods of 
poor function; and even the lack of discriminating techniques to diagnose 
rejection in its early and most reversible pr~ses. 
, 
• 
, 
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ILLusrRATIO~IS 
FIG. 1 --- F~~damenta1 difference between autografts (left) and hamografts 
(right). Tissues transferred between identi~a1 twL~S behave as autografts. 
They are termed isografts and are not rejected. (From Surge C1in. N. A. 
42:55, 1962; by permission of 1,1. B. Saunders c,;'~). 
. ..... 
FIG. 2 --- Diffusion chamber experiment, after Algire. The enclosed homo-
graft which is protected from physical contact with lymphocytes can sur-
vive for protracted periods. (From Surge C1in. N. A. 42:55, 1962; qy 
permission of H. B. Saunders Co.). 
FIG. 3 Development .of a rejection crisis less than 36 hours post-
transplantation. Although transia~t anuria resulted, the process ~~ 
a dialysis (D) was required before adequate function returned. Each 
arrow is 200 ~g Actinomycin C intravenously. This patient, whose trens-
plantation was on July 8, 1963, still r~s excellent function of the same 
homograft almost 8 1/2 years later. It is probable that presensitization 
had occurred in this case and that the violent and early crisis \laS a 
seconu ~9t or accelerated rejection. (~ permission of Surg. Gynec. 
Obstet. 118:819, 1964). 
, 
FIG. 4 --- A homograft re:noved a i'e"", hours after revascularization. The 
vasc.ill.ar clamps, the kidney became pink for a few seconds;, then deeply 
.. 
cyanotic. Upper --- note the cortical devascularization and dye staining 
at the cortical-medullary ~unction. Lower --- In the histopathologic 
section, note the occlusion of small arteries and glomerular capillaries. 
(H andE,XJ2) (By permission of Surge Gynec. Obstet. 118:819, 1964). 
FIG. 5 --- The preparation in the horse of heterologous antilymphocyte 
globulin for use in patients. (~permission or W. B. Saunders 80., 1968) • 
.. . : .... 
, 
FIG. 6 --- Classical rejection crisis in a patient treated ~th azathio-
prine (Imuran) to which prednisone was added. Deterioration of renal fUnc-
tion began 19 days after transplantation. All stigmata of rejection were 
present except for acute hypertension and weight gain, which were suc-
cessful1y prevented b.Y medical treatment. Acti C --- Actinomycin C; LN 
Left nephrectomy at time of transplantation; RN --- Right nephrectomy. 
(By permission of Surge Gynec. Obstet. 117:385, 1963). 
FIG. 7 --- The course of a patient who received antilymphocyte globulin 
(ALG) before and for the first four months after renal homotransplantation. 
The donor was an older brother. There was no early rejection. Prednisone 
therapy was started 40 days postoperatively because of the high rises 
in the serologic titers which indicated a host response against the in-
jectPod ~oreign protein and which warned against a possible anaphylactic 
react:l.oi. Note the insidious onset of late rej ection after cessation of 
t 
globulin therapy. This was treated by increasing the- ma~tenance dose of 
ster~ids. (By permission ~f Surge Gynec. Obstet. 126:1023,·1968)~ 
FIG. 8 --- The first 60 days after the transplantation' of a kidney from a 
• 
mother to her daugnter. Although the rejection crisis after a week was a 
se.vere one, it was easily and completely reversed •. Note that leukopenia 
was never produced ~I the daily doses of cyclophosphamide that were usually 
between 0.5 to 1~0 mg per kg/day~ ALG --~ horse antiIJ~p~ocyte globuiin; 
BUN --- blood urea nitrogen; CCr --- creatinine clearance; HBC -- ",hite 
". 
blood ce11 count; ARROW --- 625 mg methyl prednisolone intravenously. 
(~ permission of Surge Gynec. Obstet. 133:981, 1971). 
FIG. 9 --- The first two postoperative years of the same patient ",hose 
early course is displayed in Fig. 6. Hote that the steroid therapy was 
discontinued after 5 months, and that eventually the maintenance azathio-
prine treatment was about half the daily dosage which at the outset did 
not prevent the onset of a moderately severe rejection. (By permission 
of Ann. Surge 162: ?~.9, 1965). 
FIG. 10 --- Hypothetical mechanisms by which non-specific immunosuppression 
may lead to selective abrogation of the host immune response. Special 
, 
susceptibility to tnese agents of a fraction of the lymphoid population 
could lead to exhaustion of a clone and, hence, tolerance. Since main-
tenance of suc~ cell lines even i~ adult life is apparently thymic depen-
dent in experimental animals, thymect~my would be expected to aid the 
. 
process; this appears to be true in :'odents, but such an effect of thymus 
. . , 
removal has not been detected in dogs or humans. A possible protective 
role is also shovn of imm~~oglobu:ins elaborated qy the !eplicating cells. 
Conceivably the antibodies could a'~t either at tpe si1:.-e of the antigen 
.' 
(enhancement) or b,y affecting the macrophage processing of the antigen. 
(From Experience ~ Hepatic TranfPlantati~n; b.Y permission of W. B. 
Saunders·Co., 1969). 
FIG. 11 --- Life survival curves of 3 groups of recipients of consan-
quineous kidneys. The patients in Series I 'Were treated with the double 
drug program of azathioprine and prednisone from 1962 to' l-farch, 1964 and, 
consequently, have potential follow-ups of S to, .. 9 1/2 years. The patients 
.. 
of Series II were ~reated from October, ~964 to April 1966 a~d, consequently, 
have potential fOllow-ups of 6 to 7 1/2 years. They received the same 
drug therapy as in Series I and, in addition, an attempt was made at donor 
selection by HL-A matching. Note that the tissue typing did not influence 
the survival curve. The recipients of Series III were treated with the 
triple drug program of azatr~oprine, prednisone, and ALG between June, 
1966 and Apri~196S; they have potential follow-ups of 4 to almost 6 years. 
In all 3 series, the denominator indicates the surviving patients whereas 
the numerator tells the number of originally transplanted kidneys tt~t are 
still functioning in those surviv~rs. 
- -
FIG. 12 --- The results after the transplantation of non~related kidneys. 
The conditions of treatment, and follow-ups and the meaning of the figures 111 
the parenthesis are the saoe as in Fig. 11. Note that the results with 
non-r£:-la~ed kidneys have been inferior to those with related grafts at 
all lev~ls of our experience. 
, 
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TABLE I. DIRECTIOn OF ACCEPTABLE MIS-lATCHED TISSUE'TRANSFER* 
. . 
.. 
o to non-O Safe 
Rh- to Rh+ Safe 
Rh+ to Rh- Relatively safe 
A to non-A Dangerous 
B to non-B Dangerous 
AB to non-AB Dangerous 
*0 is universal donor. 
AB is universal recipient., 
, 
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